Provider review
Hims review
A named microdosing plan on a branded product, with a membership under every price.
Almost every microdose on this site is compounded. This one is attached to the FDA-approved oral semaglutide, so a small dose does not also mean taking on the compounding question.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Hims
From $149/mo oral, $199/mo pen, $299/mo Zepbound, membership required
- Vs median
- Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Prices the low dose on its own
- Dispensed
- Not a compounded product
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Almost every low-dose option reviewed on this site is a compounded preparation, which means choosing a small dose usually also means accepting a product no regulator has cleared. Hims is the exception worth knowing about: it carries a named microdosing plan on the branded, FDA-approved oral semaglutide. For a reader who wants to hold a small dose and would rather not add the compounding question on top, that combination is genuinely uncommon and it is the reason to look here at all. The wider lineup is broad and openly priced — oral and injectable, both molecules, several branded products with a figure against each, all visible before any intake. What those figures do not do is add up to what you pay. Each one is a starting figure, and each is marked as requiring a membership, with that membership a separate recurring charge rather than something folded into the number on the card. So the published price is the floor of one of two charges. Anyone setting it beside a flat all-in figure from a compounded seller is comparing two different things, and should work out the membership and the medication together before concluding this is the cheaper way to stay small.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a low dose without also taking on a compounded preparation.
- You want oral and injectable options for both molecules priced on one page.
- You want approved products at their label doses rather than a compounded copy.
Look elsewhere if
- You are comparing against flat all-in pricing. There is a separate membership here.
- Every figure is a starting point, so none of them is a ceiling.
- The injectable pens cost substantially more than the oral products.
What it actually costs
Price as published
★★ A "Microdosing Plan" carried as its own option on the Wegovy oral pill from $149/month — a named microdose attached to a BRANDED, FDA-approved product rather than a compounded one, which is rare enough to be the reason to look · the wider lineup: Wegovy pill, Ozempic pill and Foundayo from $149/month, Wegovy pen and Ozempic from $199/month, Zepbound KwikPen and Zepbound vial from $299/month · every figure is marked "membership required" and every one is a "from", so the published number is a floor with a subscription underneath it rather than a total · a $39 entry charge appears at the start, and a $1,899 figure sits elsewhere in the lineup · all doses are the approved label doses of approved products
- Vs median
- Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Prices the low dose on its own
Publishes a price for a microdose track, but no standard-dose price alongside it — so you can cost the low dose, you just cannot see what it saves you.
17 of the 373 programs we track price a small dose this way. ★★ A named microdosing plan attached to a BRANDED, FDA-approved oral semaglutide rather than a compounded preparation — rare among the providers here. It carries a figure, and the standard products carry figures too, but every one is a "from" with a separate required membership underneath, so the microdose price cannot be set against a full-dose price cleanly enough to call it cheaper.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Billed separately
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Carries a named microdosing plan on a branded, FDA-approved product rather than a compounded one.
- Prices oral and injectable options for both molecules openly before any intake.
- Every product on the lineup is an approved medication at its label doses.
Pharmacy, labs and oversight
Hims dispenses through a Not applicable — branded, FDA-approved products facility. No bloodwork is required before you start. A clinician review is billed separately.
Transparency check
3 of 4 published openly
What Hims publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Almost every microdose on this site is a compounded preparation. This one is not: Hims attaches a named microdosing plan to the branded, FDA-approved oral semaglutide, which means a reader wanting a small dose can have one without also taking on the compounding question. That combination is genuinely uncommon and it is the reason this row exists. The rest of the lineup is broad and priced openly — oral and injectable, semaglutide and tirzepatide, several branded products with a figure against each, all visible before any intake. What the figures do not do is total up. Each is a "from", each is marked membership required, and the membership is a separate recurring charge rather than something folded into the number on the card. So the published price is the floor of one of two charges, and anybody comparing it against a flat all-in figure elsewhere on this site is comparing different things. Work out the membership and the medication together before deciding this is the cheapest way to hold a small dose.
The honest cons
Every price is a "from" with a separate required membership underneath it.
- The published figure is one of two charges, so it is not the monthly total.
- The cheapest rungs are the oral products; the injectable pens cost substantially more.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Hims is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#199 of 373
Ordered with the companies that pay us first, and Hims is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Aurelius Health Group
$89 first month, then $199/mo
- Vs median
- $30/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Prices the low dose on its own
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Aurelius Health Group review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.